4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Arrowhead Pharmaceuticals, Inc. (ARWR) operates in the Biotechnology industry and is headquartered in Pasadena, United States with about 711 employees. Its market capitalization is roughly $12 billion. In the fiscal year ended 2025-09-30, ARWR reported $829M in revenue and ($2M) in net income.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Interactive charts & full statements → Open the ARWR valuation workbench →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $829M | $4M | $241M | $243M | — |
| Operating Income (EBIT) | $98M | ($601M) | ($205M) | ($178M) | — |
| Net Income | ($2M) | ($600M) | ($205M) | ($176M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $74M | $264M | $256M | $28M | $543M | — |
| Operating Income (EBIT) | ($141M) | $41M | $44M | ($166M) | $381M | — |
| Net Income | ($133M) | $31M | ($24M) | ($175M) | $370M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.1B | $766M | $692M | — |
| Total Liabilities | $882M | $949M | $478M | $274M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ARWR viewer.
About TickerBase · Data methodology & sources